So, Alexander https://orcid.org/0000-0002-7183-5414
Article History
Received: 20 September 2019
Accepted: 3 October 2019
First Online: 11 November 2019
Ethics approval and consent to participate
: Not applicable.
: Not applicable.
: AS has served on the advisory board of Novartis and SOBI during the development of anti-IL1 therapies for gout.